(Q73836253)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337298%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Prognostic value of three molecular forms of prostate-specific antigen ratios in patients with prostate adenocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337298%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

main subject

prostate adenocarcinoma

1 reference

T Okegawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337298%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Kato

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337298%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

K Nutahara

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337298%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

E Higashihara

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337298%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 May 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337298%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337298%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337298%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337298%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

936-942

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337298%20AND%20SRC:MED&resulttype=core&format=json

Prostate specific antigen predominantly forms a complex with alpha 1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

The use of percent free prostate specific antigen for staging clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

The free-to-total serum prostate specific antigen ratio for staging prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

Free, complexed and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

Preoperative nested reverse transcription-polymerase chain reaction for prostate specific membrane antigen predicts biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

Percent free prostate-specific antigen values in men with recurrent prostate cancer after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

Cell-cell interaction in prostate gene regulation and cytodifferentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

Change in morphological and functional cytodifferentiation induced by seminal vesicle mesenchyme in cell suspensions of rat Dunning prostatic adenocarcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901125-0

7 January 2021

10.1016/S0090-4295(00)01125-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337298%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference